Explore global clinical trial activity by specialty, country, phase, and therapeutic area. Create your ClinVio™ profile to be considered for adjudication, medical review, advisory, and specialist-support opportunities.
Live Trial Activity
Calculated from the trials currently indexed in ClinVio. Hover or focus any metric for its definition and source.
500
Total Trials Indexed
500
Currently Recruiting
14
Medical Specialties
81
Countries
54
Phase II Trials
26
Phase III Trials
+500
Added (30 days)
Live from ClinicalTrials.gov & EU Register
500 matching · 500 total indexed
Showing 1–12 of 500 matching trials
The purpose of this study is to determine the safety and feasibility of sequencing psilocybin therapy with a short-duration, aiTBS protocol (Stanford Accelerated Intelligent Neuromodulation Therapy, or SAINT) in individuals with treatment-resistant major depressive disorder.
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
The purpose of this research is to determine whether a new stress management and mindfulness program can improve quality of life in individuals with sickle cell disease. The program is based on a number of empirically supported treatments including techniques from cognitive-behavioral therapy like overcoming motivational barriers to self-care, learning to see things as accurately as possible, practicing assertive communication, relaxation exercises like deep slow breathing, mindfulness meditation, and other stress management strategies.
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
The aim of this observational study is to examine real-world clinical practice regarding the use of vasopressin as a second-line vasopressor in adult patients admitted to Intensive Care Units (ICUs) with septic shock. The study focuses on critically ill adults (≥18 years) diagnosed with septic shock and treated with norepinephrine and vasopressin. The main research questions are: * Does early initiation of vasopressin-defined by the norepinephrine dose at the time of introduction-reduce mortality in patients with septic shock? * What is the impact of vasopressin as a second vasopressor on renal function and the progression of organ dysfunction in septic shock patients? Participants will: * Be admitted to an ICU with a diagnosis of septic shock. * Receive vasopressin as an adjunct to norepinephrine for hemodynamic support. * Be monitored daily throughout their ICU stay, with data collected through a dedicated REDCap system. * Have relevant clinical data pseudonymized and incorporated into the study database for statistical analysis.
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
Hybrid positron emission tomography/computed tomography (PET/CT) has now become available to detect tumors in patients with multiple myeloma. The radioactive glucose 18F-fluorodeoxyglucose (FDG) is the most widely used tracer but findings suggest that PET/CT reveal more lesions when using FCH. In this study, FDG is compared with a more recent metabolic tracer, 18F-fluorocholine (FCH), for the detection of multiple myeloma lesions at time of initial extension assessment. The principal objective of this sudy is to compare the number of suspected hypermetabolic foci of myeloma detected by 18F-fluorocholine PET and by 18F-fluorodeoxyglucose PET during the initial extension assessment.
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
The goal of the DRAGON PLC clinical trial is to determine whether portal vein embolization (PVE) combined with hepatic vein embolization (HVE) improves resectability and overall survival in patients with initially unresectable primary liver cancer compared to standard PVE alone. This trial specifically focuses on patients with hepatocellular carcinoma and cholangiocarcinoma. The main questions this trial aims to answer are whether combined PVE and HVE increases the proportion of patients who become resectable within 3 weeks and improves 5-year overall survival compared to PVE alone by enhancing liver hypertrophy. Participants will: * Undergo either standard PVE or combined PVE and HVE. * Have regular imaging to assess liver resectability. * Be monitored for survival outcomes up to 5 years after intervention.
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
The purpose of this randomized controlled trial is to evaluate whether a psychodrama group therapy intervention can reduce unresolved breakup distress and improve dyadic adjustment in adults currently involved in romantic relationships who have experienced a significant previous breakup. The main questions this study aims to answer are: * Does participation in psychodrama group therapy reduce breakup distress compared with a waiting-list control condition? * Does participation in psychodrama group therapy improve dyadic adjustment and relationship functioning compared with a waiting-list control condition? The researchers will compare participants receiving the psychodrama group therapy intervention with participants in a waiting-list control condition to determine whether the intervention leads to greater improvements in breakup distress, dyadic adjustment, psychological functioning, relationship quality, and sexual satisfaction. Participants will: * complete assessments at baseline, 16 weeks, and 42 weeks; * participate in a 15-session weekly psychodrama group therapy program (intervention group only); * complete questionnaires assessing breakup distress, dyadic adjustment, psychological outcomes, relationship quality, and sexual satisfaction.
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
Acute post-mastectomy pain can cause adverse impacts on the patients as delayed discharge from post-operative recovery area, impairs pulmonary and immune functions, increases risk of ileus, thromboembolism, myocardial infarction and may lead to increased length of hospital stay. It is also an important factor leading to the development of chronic post mastectomy pain syndrome (PMPS) in almost half of the patients. Various regional anesthetic techniques have been described for postoperative pain relief after mastectomy, for example, thoracic epidural anesthesia, intercostal nerve block, paravertebral block, serratus anterior plane block, and pectoral nerve I and II blocks. All of them offer satisfactory pain relief after mastectomy. Erector spinae plane block is a novel para-spinal regional anesthesia technique, , promises to provide effective visceral as well as somatic analgesia after carcinoma of the breast surgeries. The ultrasound-guided rhomboid intercostal block sub-serratus plane block (RISS) is a novel analgesic technique The RISS block anesthetizes the lateral cutaneous branches of the thoracic intercostal nerves and can be used in multiple clinical settings for chest wall and upper abdominal analgesia
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
This study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adults with lichen planopilaris (LPP) or central centrifugal cicatricial alopecia (CCCA) over a 48-week treatment period. Approximately 30 participants will be enrolled: 15 CCCA and 15 LPP. The study will take place at the Icahn School of Medicine at Mount Sinai (ISMMS).
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
A Ph.2, single-arm, monocentric, trial of neo-adjiuvant chemo-immunotherapy for stage III, PD-L1 positive, NSCLC. Adults and smokers (past or current) diagnosed with stage III NSCLC without driver molecular alterations (EGFR, ALK, ROS1, RET).
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
This clinical trial investigates the safety, side effects, and effectiveness of combining an immunotherapy drug called dinutuximab-beta with standard induction chemotherapy for patients newly diagnosed with high-risk neuroblastoma. Dinutuximab-beta is an antibody designed to target specific molecules on the surface of neuroblastoma cells. In this pilot study, enrolled patients will receive dinutuximab-beta as a continuous intravenous infusion alongside a standard 6-cycle induction chemotherapy regimen. The primary goals of this study are to monitor how well patients tolerate the new combination treatment closely and to determine how effectively tumors shrink before patients proceed to the next phase of their standard consolidation therapy.
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
The purpose of this study is to investigate whether transcranial direct-current stimulation (tDCS) will engage reward-related brain circuitry, more specifically the uncinate fasciculus (UF) tract, which connects the orbitofrontal cortex (OFC) and nucleus accumbens (NAcc) regions. Also to evaluate whether the changes in the fractional anisotropy (FA) of the UF tract are associated with changes of clinical symptoms of anhedonia and finally to investigate the moderation role of simulated electric fields (EFs) in an association between FA of the UF and symptoms of anhedonia.
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
Osteotomies are among the oldest orthopedic treatments, in use for over 2000 years and still commonly employed. The basic principle involves making a bone cut to allow the realignment of the limb segment affected by deformity. Today, new knowledge and technologies, understanding of bone healing mechanisms, and the introduction of new fixation methods have made osteotomies one of the preferred treatments for early knee arthritis. They serve as an alternative to joint prosthesis implantation in young patients with medium to high functional demand. Medial knee osteoarthritis is a pathology increasingly prevalent in today's population. The resulting varus deformity leads to a shift in the load axis on the medial tibial plateau. Osteotomy in this context becomes a therapeutic tool capable of restoring the correct mechanical axis of the lower limb and delaying or avoiding the progression of arthritis, thus avoiding the need for joint replacement. The two most commonly used techniques are the Closing Wedge Lateral High Tibial Osteotomy (LCW-HTO) and the Opening Wedge Medial High Tibial Osteotomy (MOW-HTO), which are high tibial osteotomies in closure with a wedge removal and in opening with a wedge insertion, respectively. The medium to long-term effects of this procedure, in terms of survival and modification of the tibial slope, have been extensively studied, as evidenced by the extensive literature on the subject. However, the effect of this intervention, in its two variants, on the progression of femoro-patellar arthritis and the height of the patella remains poorly investigated to date.
Source: Verified clinical trial databases & partner networks· Updated Oct 14, 2026
Opportunities by Specialty
Live counts of indexed trials per specialty. Counts are calculated from current trial data, not projected.
How ClinVio Works
ClinVio is more than a trial listing — it is the path from interest to engagement.
Browse indexed trials by specialty, country, phase, and therapeutic area to see where specialist engagement is happening.
Add your specialization, experience, credentials, and availability. Takes only a few minutes.
ClinVio matches your profile to adjudication, review, advisory, and specialist-support opportunities.
Engage on flexible terms with sponsors and CROs, contribute your expertise, and receive compensation.
Why Doctors Join ClinVio
No guaranteed placements or income promises — just relevant opportunities and operational support.
Choose opportunities that fit your schedule — typically 10–40 hours per month, fully remote.
Engage with sponsors and CROs running trials across multiple countries and therapeutic areas.
Hourly, per-case, or monthly compensation models based on the type and duration of engagement.
Your professional information is encrypted in transit and accessed only with role-based permissions.
Receive notifications when new trials match your specialty, phase, and country preferences.
Our team supports onboarding, contracting, and ongoing engagement logistics end-to-end.
Find medical experts for adjudication, review and specialist-support roles.
Trust, Privacy & Security
We describe our actual controls and plans accurately. We do not claim certifications or regulatory approvals that have not been completed.
All data in transit is encrypted using modern TLS standards.
Doctor profile data is only exposed to authorized sponsors after approval.
Profile sharing follows a staged disclosure model with consent tracking.
We follow privacy workflows intended to align with GDPR principles.
Profile views and key data access events are logged for accountability.
SOC 2 readiness planned · HIPAA applicability under review.
Compliance status: ClinVio does not claim HIPAA compliance, SOC 2 certification, FDA approval, or FDA compliance. HIPAA applicability is currently under review and SOC 2 readiness is planned. Regulatory alignments are described as design objectives, not completed certifications.
ClinVio connects medical specialists with sponsors and CROs for clinical trial adjudication, medical review, advisory and specialist-support engagements.
Submit the doctor registration request with your name, work email, primary specialty and professional background. The ClinVio team reviews your details and sends account access after approval.
Open doctor registrationNo. Public trial records describe clinical trial activity. A ClinVio engagement depends on a specific requirement, matching, review and agreement with the relevant parties.
The doctor and company portals support engagement contracts, time recording, timesheet review and payment tracking. Compensation and work expectations are set through the applicable engagement and contract.
The Trust Center links to ClinVio policies and describes its security and compliance program status. You can submit a privacy request for review through the Privacy Request page.
Visit the Trust CenterClinVio Blog
Explore clinical research roles, specialist opportunities and practical guides for doctors.
ClinVio InsightsA complete guide to clinical research roles, eligibility requirements and practical steps for doctors who want to get involved in clinical trials.
Read articleCreate your professional profile in minutes and start receiving relevant clinical trial opportunity alerts.
Create Your Doctor Profile